Massagno, Switzerland

Ibsa Institut Biochimique Sa

Calculating rank
USPTO Granted Patents = 9

% Expired Patents = 11.1



Trademarks = 10

Forward Citations = 36

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Tiziano Fossati (2 out of 8 patents)

silverMedal Andrea Alimonti (2 out of 4 patents)

bronzeMedal Andrea Maria Giori (2 out of 6 patents)

4.  Antonio Mutterle (2 out of 4 patents)

5.  Taiki Shibata (1 out of 7 patents)

6.  Elisabetta Donati (1 out of 15 patents)

7.  Nadia Puppini (1 out of 5 patents)

8.  Kenichi Hattori (1 out of 9 patents)

9.  Takashi Kamakura (1 out of 8 patents)

10.  Pasqua Anna Oreste (1 out of 13 patents)

11.  Giorgio Zoppetti (1 out of 21 patents)

12.  Yuichiro Mabuchi (1 out of 2 patents)

13.  Irina Rapaport (1 out of 5 patents)

14.  Paolo Lualdi (1 out of 3 patents)

15.  Elisabetta Donati-Pedemonti (1 out of 1 patent)


9 patents:

Company Overview
Ibsa Institut Biochimique Sa is a Swiss pharmaceutical company that specializes in research, development, and production of medical products in the fields of endocrinology, orthopedics, and rheumatology. With a focus on innovation and quality, Ibsa is dedicated to improving the health and well-being of patients globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#1 in Massagno

#1,202 in Switzerland

Massagno, CH
Massagno, Switzerland
Forward Citations = 36

19 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ibsa Institut Biochimique Sa. Retrieved from https://idiyas.com/company/ibsa-institut-biochimique-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…